BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kay E, Cuccui J, Wren BW. Recent advances in the production of recombinant glycoconjugate vaccines. NPJ Vaccines 2019;4:16. [PMID: 31069118 DOI: 10.1038/s41541-019-0110-z] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 16.3] [Reference Citation Analysis]
Number Citing Articles
1 Shit P, Sahaji S, Misra AK. Convergent synthesis of the hexasaccharide repeating unit of the capsular polysaccharide of klebsiella serotype K-34. Tetrahedron 2022. [DOI: 10.1016/j.tet.2022.133159] [Reference Citation Analysis]
2 Williams AJ, Warfel KF, Desai P, Li J, Lee J, Wong DA, Sobol SE, Jewett MC, Chang Y, Delisa MP. A low-cost recombinant glycoconjugate vaccine confers immunogenicity and protection against enterotoxigenicEscherichia coliinfections in mice.. [DOI: 10.1101/2022.10.31.514630] [Reference Citation Analysis]
3 Hammel SC, Nordone S, Zhang S, Lorenzo AM, Eichner B, Moody MA, Harrington L, Gandee J, Schmidt L, Smith S, Stapleton HM, Hoffman K. Infants' diminished response to DTaP vaccine is associated with exposure to organophosphate esters. Science of The Total Environment 2022;837:155782. [DOI: 10.1016/j.scitotenv.2022.155782] [Reference Citation Analysis]
4 Romano MR, Berti F, Rappuoli R. Classical- and bioconjugate vaccines: comparison of the structural properties and immunological response. Curr Opin Immunol 2022;78:102235. [PMID: 35988326 DOI: 10.1016/j.coi.2022.102235] [Reference Citation Analysis]
5 Mukherjee MM, Ghosh R, Hanover JA. Recent Advances in Stereoselective Chemical O-Glycosylation Reactions. Front Mol Biosci 2022;9:896187. [DOI: 10.3389/fmolb.2022.896187] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Zhao X, Huang Y, Zhou S, Ao J, Cai H, Tanaka K, Ito Y, Ishiwata A, Ding F. Recent Chemical and Chemoenzymatic Strategies to Complex-Type N-Glycans. Front Chem 2022;10:880128. [DOI: 10.3389/fchem.2022.880128] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Pančík F, Pakanová Z, Mečárová J, Čížová A, Bystrický S, Kozmon S, Baráth P. Fragmentation analysis of O-specific polysaccharide from bacteria Vibrio cholerae O139 by MALDI-TOF and LC/ESI-MS/MS. Eur J Mass Spectrom (Chichester) 2022;:14690667221099119. [PMID: 35521830 DOI: 10.1177/14690667221099119] [Reference Citation Analysis]
8 Kint N, Dubois T, Viollier PH. Genetic glyco-profiling and rewiring of insulated flagellin glycosylation pathways.. [DOI: 10.1101/2022.03.25.485807] [Reference Citation Analysis]
9 Nicolardi S, Danuser R, Dotz V, Domínguez-Vega E, Al Kaabi A, Beurret M, Anish C, Wuhrer M. Glycan and Protein Analysis of Glycoengineered Bacterial E. coli Vaccines by MALDI-in-Source Decay FT-ICR Mass Spectrometry. Anal Chem 2022. [PMID: 35293727 DOI: 10.1021/acs.analchem.1c04690] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Jiang X, Bai J, Zhang H, Yuan J, Lu G, Wang Y, Jiang L, Liu B, Huang D, Feng L. Development of an O-polysaccharide based recombinant glycoconjugate vaccine in engineered E. coli against ExPEC O1. Carbohydr Polym 2022;277:118796. [PMID: 34893224 DOI: 10.1016/j.carbpol.2021.118796] [Reference Citation Analysis]
11 Hacıosmanoğlu N, Köse S, Ostaku J, Köksaldi İÇ, Saltepe B, Şeker UÖŞ. Design of synthetic biological devices for detection and targeting human diseases. New Frontiers and Applications of Synthetic Biology 2022. [DOI: 10.1016/b978-0-12-824469-2.00028-2] [Reference Citation Analysis]
12 Manjunathachar HV, Azhahianambi P, Kumar B, Ghosh S. Screening for the “Achilles Heel” of Hyalomma anatolicum Ticks by RNA Interference Technology and an Update on Anti-Tick Vaccine Design. Vaccine Design 2022. [DOI: 10.1007/978-1-0716-1888-2_18] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Anish C, Beurret M, Poolman J. Combined effects of glycan chain length and linkage type on the immunogenicity of glycoconjugate vaccines. NPJ Vaccines 2021;6:150. [PMID: 34893630 DOI: 10.1038/s41541-021-00409-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
14 Abouelhadid S, Atkins E, Kay E, Passmore I, North SJ, Lehri B, Hitchen P, Bakke E, Rahman M, Bosse J, Li Y, Terra VS, Langford P, Dell A, Wren BW, Cuccui J. Development of a novel glycoengineering platform for the rapid production of conjugate vaccines.. [DOI: 10.1101/2021.11.25.470047] [Reference Citation Analysis]
15 Zhu H, Rollier CS, Pollard AJ. Recent advances in lipopolysaccharide-based glycoconjugate vaccines. Expert Rev Vaccines 2021;:1-24. [PMID: 34550840 DOI: 10.1080/14760584.2021.1984889] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
16 Pratama F, Linton D, Dixon N. Genetic and process engineering strategies for enhanced recombinant N-glycoprotein production in bacteria. Microb Cell Fact 2021;20:198. [PMID: 34649588 DOI: 10.1186/s12934-021-01689-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Mauri M, Sannasiddappa TH, Vohra P, Corona-Torres R, Smith AA, Chintoan-Uta C, Bremner A, Terra VS, Abouelhadid S, Stevens MP, Grant AJ, Cuccui J, Wren BW; Glycoengineering of Veterinary Vaccines Consortium. Multivalent poultry vaccine development using Protein Glycan Coupling Technology. Microb Cell Fact 2021;20:193. [PMID: 34600535 DOI: 10.1186/s12934-021-01682-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
18 Adegbite A, McCarthy PC. Recent and Future Advances in the Chemoenzymatic Synthesis of Homogeneous Glycans for Bacterial Glycoconjugate Vaccine Development. Vaccines (Basel) 2021;9:1021. [PMID: 34579258 DOI: 10.3390/vaccines9091021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Pan C, Yue H, Zhu L, Ma GH, Wang HL. Prophylactic vaccine delivery systems against epidemic infectious diseases. Adv Drug Deliv Rev 2021;176:113867. [PMID: 34280513 DOI: 10.1016/j.addr.2021.113867] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
20 Weyant KB, Liao J, Jesus MR, Jaroentomeechai T, Moeller TD, Hoang-phou S, Pal S, Gilmore SF, Singh R, Putnam D, Locher C, de la Maza LM, Coleman MA, Delisa MP. A modular platform for on-demand vaccine self-assembly enabled by decoration of bacterial outer membrane vesicles with biotinylated antigens.. [DOI: 10.1101/2021.08.24.457488] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Zhu Z, Antenucci F, Villumsen KR, Bojesen AM. Bacterial Outer Membrane Vesicles as a Versatile Tool in Vaccine Research and the Fight against Antimicrobial Resistance. mBio 2021;12:e0170721. [PMID: 34372691 DOI: 10.1128/mBio.01707-21] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
22 Su L, Feng Y, Wei K, Xu X, Liu R, Chen G. Carbohydrate-Based Macromolecular Biomaterials. Chem Rev 2021. [PMID: 34338501 DOI: 10.1021/acs.chemrev.0c01338] [Cited by in Crossref: 35] [Cited by in F6Publishing: 46] [Article Influence: 35.0] [Reference Citation Analysis]
23 Fatoba AJ, Adeleke VT, Maharaj L, Okpeku M, Adeniyi AA, Adeleke MA. Immunoinformatics Design of Multiepitope Vaccine Against Enterococcus faecium Infection. Int J Pept Res Ther 2021;27:2183-98. [DOI: 10.1007/s10989-021-10245-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
24 Samaras JJ, Mauri M, Kay EJ, Wren BW, Micheletti M. Development of an automated platform for the optimal production of glycoconjugate vaccines expressed in Escherichia coli. Microb Cell Fact 2021;20:104. [PMID: 34030723 DOI: 10.1186/s12934-021-01588-1] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
25 Seeberger PH. Discovery of Semi- and Fully-Synthetic Carbohydrate Vaccines Against Bacterial Infections Using a Medicinal Chemistry Approach. Chem Rev 2021;121:3598-626. [PMID: 33794090 DOI: 10.1021/acs.chemrev.0c01210] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 30.0] [Reference Citation Analysis]
26 Li X, Pan C, Liu Z, Sun P, Hua X, Feng E, Yu Y, Wu J, Zhu L, Wang H. Safety and immunogenicity of a new glycoengineered vaccine against Acinetobacter baumannii in mice. Microb Biotechnol 2021. [PMID: 33755314 DOI: 10.1111/1751-7915.13770] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
27 Jiang X, Bai J, Yuan J, Zhang H, Lu G, Wang Y, Jiang L, Liu B, Wang L, Huang D, Feng L. High efficiency biosynthesis of O-polysaccharide-based vaccines against extraintestinal pathogenic Escherichia coli. Carbohydr Polym 2021;255:117475. [PMID: 33436239 DOI: 10.1016/j.carbpol.2020.117475] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
28 Melamed J, Brockhausen I. Biosynthesis of Bacterial Polysaccharides. Comprehensive Glycoscience 2021. [DOI: 10.1016/b978-0-12-819475-1.00097-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Yuan J, Jiang X, Zhang H, Bai J, Zhang J, Wang Y, Lu G, Xu H, Liu H, Liu B, Huang D. Construction and optimization of a microbial platform for sustainable biosynthesis of poly-N-acetyllactosamine glycoprotein in the cytoplasm for detecting tumor biomarker galectin-3. Green Chem 2021;23:2668-2684. [DOI: 10.1039/d0gc04331a] [Reference Citation Analysis]
30 Duttaroy AK. Polysaccharides and their bioactivity and biomedical applications. Evidence-Based Nutrition and Clinical Evidence of Bioactive Foods in Human Health and Disease 2021. [DOI: 10.1016/b978-0-12-822405-2.00010-4] [Reference Citation Analysis]
31 Fernández L, Cima-cabal MD, Duarte AC, Rodriguez A, García P, García-suárez MDM. Developing Diagnostic and Therapeutic Approaches to Bacterial Infections for a New Era: Implications of Globalization. Antibiotics 2020;9:916. [DOI: 10.3390/antibiotics9120916] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
32 Pratama F, Linton D, Dixon N. Genetic and process engineering strategies for enhanced recombinant N-glycoprotein production in bacteria.. [DOI: 10.1101/2020.11.12.379875] [Reference Citation Analysis]
33 Balijepalli AS, Grinstaff MW. Poly-Amido-Saccharides (PASs): Functional Synthetic Carbohydrate Polymers Inspired by Nature. Acc Chem Res 2020;53:2167-79. [PMID: 32892620 DOI: 10.1021/acs.accounts.0c00263] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
34 Rexer T, Laaf D, Gottschalk J, Frohnmeyer H, Rapp E, Elling L. Enzymatic Synthesis of Glycans and Glycoconjugates. Adv Biochem Eng Biotechnol 2021;175:231-80. [PMID: 33052414 DOI: 10.1007/10_2020_148] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
35 Barbosa JR, Carvalho Junior RN. Occurrence and possible roles of polysaccharides in fungi and their influence on the development of new technologies. Carbohydr Polym 2020;246:116613. [PMID: 32747253 DOI: 10.1016/j.carbpol.2020.116613] [Cited by in Crossref: 13] [Cited by in F6Publishing: 19] [Article Influence: 6.5] [Reference Citation Analysis]
36 Murphy N, Rooney B, Bhattacharyya T, Triana-Chavez O, Krueger A, Haslam SM, O'Rourke V, Pańczuk M, Tsang J, Bickford-Smith J, Gilman RH, Tetteh K, Drakeley C, Smales CM, Miles MA. Glycosylation of Trypanosoma cruzi TcI antigen reveals recognition by chagasic sera. Sci Rep 2020;10:16395. [PMID: 33009443 DOI: 10.1038/s41598-020-73390-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
37 Pan C, Wu J, Qing S, Zhang X, Zhang L, Yue H, Zeng M, Wang B, Yuan Z, Qiu Y, Ye H, Wang D, Liu X, Sun P, Liu B, Feng E, Gao X, Zhu L, Wei W, Ma G, Wang H. Biosynthesis of Self-Assembled Proteinaceous Nanoparticles for Vaccination. Adv Mater 2020;32:e2002940. [PMID: 32881121 DOI: 10.1002/adma.202002940] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 9.0] [Reference Citation Analysis]
38 Geddes-McAlister J. Pathogenesis of Fungal and Bacterial Microbes. Pathogens 2020;9:E602. [PMID: 32718012 DOI: 10.3390/pathogens9080602] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Kightlinger W, Warfel KF, DeLisa MP, Jewett MC. Synthetic Glycobiology: Parts, Systems, and Applications. ACS Synth Biol 2020;9:1534-62. [PMID: 32526139 DOI: 10.1021/acssynbio.0c00210] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 15.5] [Reference Citation Analysis]
40 Dow JM, Mauri M, Scott TA, Wren BW. Improving protein glycan coupling technology (PGCT) for glycoconjugate vaccine production. Expert Review of Vaccines 2020;19:507-27. [DOI: 10.1080/14760584.2020.1775077] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
41 Pagliusi S, Dennehy M, Homma A. Two decades of vaccine innovations for global public good: Report of the Developing Countries' Vaccine Manufacturers Network 20th meeting, 21-23 october 2019, Rio de Janeiro, Brazil. Vaccine 2020;38:5851-60. [PMID: 32535016 DOI: 10.1016/j.vaccine.2020.05.062] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
42 Berti F, Micoli F. Improving efficacy of glycoconjugate vaccines: from chemical conjugates to next generation constructs. Curr Opin Immunol 2020;65:42-9. [PMID: 32361591 DOI: 10.1016/j.coi.2020.03.015] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 8.5] [Reference Citation Analysis]
43 Ukaegbu OI, DeMeester KE, Liang H, Brown AR, Jones ZS, Grimes CL. Utility of bacterial peptidoglycan recycling enzymes in the chemoenzymatic synthesis of valuable UDP sugar substrates. Methods Enzymol 2020;638:1-26. [PMID: 32416908 DOI: 10.1016/bs.mie.2020.02.014] [Reference Citation Analysis]
44 Lamazares E, Gutiérrez F, Hidalgo A, Gutiérrez NA, Espinoza FI, Sánchez O, Cortez-San Martín M, Mascayano C, González J, Saavedra J, Altamirano C, Mansur M, Ruiz Á, Toledo JR. A Heterologous Viral Protein Scaffold for Chimeric Antigen Design: An Example PCV2 Virus Vaccine Candidate. Viruses 2020;12:E385. [PMID: 32244384 DOI: 10.3390/v12040385] [Reference Citation Analysis]
45 Manna T, Gucchait A, Misra AK. Convenient synthesis of the pentasaccharide repeating unit corresponding to the cell wall O-antigen of Escherichia albertii O4. Beilstein J Org Chem 2020;16:106-10. [PMID: 32082429 DOI: 10.3762/bjoc.16.12] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
46 Colijn C, Corander J, Croucher NJ. Designing ecologically optimized pneumococcal vaccines using population genomics. Nat Microbiol 2020;5:473-85. [PMID: 32015499 DOI: 10.1038/s41564-019-0651-y] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 13.0] [Reference Citation Analysis]
47 Lin L, Qiao M, Zhang X, Linhardt RJ. Site-selective reactions for the synthesis of glycoconjugates in polysaccharide vaccine development. Carbohydrate Polymers 2020;230:115643. [DOI: 10.1016/j.carbpol.2019.115643] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
48 Huszczynski SM, Lam JS, Khursigara CM. The Role of Pseudomonas aeruginosa Lipopolysaccharide in Bacterial Pathogenesis and Physiology. Pathogens 2019;9:E6. [PMID: 31861540 DOI: 10.3390/pathogens9010006] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 15.7] [Reference Citation Analysis]
49 Sanz Moreno JC, Ramos Blázquez B. Papel del estado de portador en el control de enfermedades infecciosas y su relación con la vacunación. REMASP 2019;2:1-8. [DOI: 10.36300/remasp.2019.020] [Reference Citation Analysis]
50 Hager FF, Sützl L, Stefanović C, Blaukopf M, Schäffer C. Pyruvate Substitutions on Glycoconjugates. Int J Mol Sci 2019;20:E4929. [PMID: 31590345 DOI: 10.3390/ijms20194929] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
51 Feldman MF, Mayer Bridwell AE, Scott NE, Vinogradov E, McKee SR, Chavez SM, Twentyman J, Stallings CL, Rosen DA, Harding CM. A promising bioconjugate vaccine against hypervirulent Klebsiella pneumoniae. Proc Natl Acad Sci U S A 2019;116:18655-63. [PMID: 31455739 DOI: 10.1073/pnas.1907833116] [Cited by in Crossref: 67] [Cited by in F6Publishing: 68] [Article Influence: 22.3] [Reference Citation Analysis]
52 Ullah S, Khalil AA, Shaukat F, Song Y. Sources, Extraction and Biomedical Properties of Polysaccharides. Foods 2019;8:E304. [PMID: 31374889 DOI: 10.3390/foods8080304] [Cited by in Crossref: 54] [Cited by in F6Publishing: 60] [Article Influence: 18.0] [Reference Citation Analysis]